NDC product
Apixaban
NDC 0115-1722 · Amneal Pharmaceuticals of New York LLC
Key facts
| Product NDC | 0115-1722 |
|---|---|
| Proprietary name | Apixaban |
| Nonproprietary name | Apixaban |
| Substances | APIXABAN |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA209810 |
| Pharmacologic classes | Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA] |
| Marketing start | Aug 31, 2018 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: